TOP STORIES

• BUSINESS Nippon Express to Set Up 4 Distribution Centers for Full-Scale Drug Logistics Biz, Aims for 15 Billion Yen Annual Sales
  January 29, 2019

• BUSINESS Xofluza Enjoys Commanding Lead with 47% Share in October-December, MHLW Data Show
  January 28, 2019

• BUSINESS Takeda’s Specialty Business Unit Boots Up with Entyvio Detailing
  January 25, 2019

• REGULATORY MHLW Unveils Outline of Cost-Effective Assessment Scheme: Chuikyo
  January 24, 2019

• BUSINESS Mitsubishi Tanabe Eyes US as 1st Launch Market, Zeroes in on Immunology/CNS: Chief
  January 22, 2019

• BUSINESS Shionogi Facing Xofluza Supply Crunch as Flu Season Gets into Full Swing
  January 21, 2019

• BUSINESS Mitsubishi Tanabe Staffers Tapping New Support System to Balance Work and Infertility, Medical Treatment
  January 18, 2019

• REGULATORY PMDA to Specify Target Overall Review Period for Regenerative Medicine Products: FY2019-2023 Plan
  January 17, 2019

• REGULATORY MHLW Won’t Necessarily Push March Announcement of New Drug Prices: Bureau Head
  January 16, 2019

• BUSINESS Japan Pharma Market Sags 2% in April-December as Pricing Overhaul Weighs: Encise
  January 15, 2019

• REGULATORY PMDA to Raise Fees and Expand Workforce to Boost Review and Safety Measures, GMP Inspection
  January 15, 2019

• COMMENTARY 2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
  January 11, 2019

• REGULATORY MHLW to Revise Biosimilar Guidelines to Increase Efficiency in Development, Review; Final Draft Expected in FY2019
  January 10, 2019

• REGULATORY MHLW Approves Amgen/Astellas’ Evenity, Gilead Sciences’ Epclusa and More
  January 9, 2019

• BUSINESS Takeda Completes £46 Billion Shire Acquisition
  January 8, 2019

• REGULATORY MHLW to Follow Up on Drug Makers’ Efforts to Observe New Detailing Guidelines
  January 7, 2019

• BUSINESS Can Daiichi Sankyo Take Big Leap in Oncology with 3 FDA Nods in FY2019?
  January 4, 2019

• BUSINESS Reata Developing Sakigake Designated DKD Drug for Alport Syndrome in Japan
  December 28, 2018

• BUSINESS Biogen Japan Set to “Make Impossible Possible” in Next 5 Years, Double Neuroscience Pipeline
  December 27, 2018

• TRENDS Top 10 PHARMA JAPAN Stories in 2018
  December 26, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• 142
• …
• Next ›
• 最終 »